Synopsys, Inc. (SNPS) Financial Research Report

Disclaimer: This content reflects the views of the author(s) as of the date indicated and is for educational and informational purposes only. It is not investment advice. Do your own due diligence with a licensed financial advisor before making any investment decisions. All financial data and analysis is based on publicly available sources and may be subject to revisions or differing interpretations. The content is for informational purposes only and does not constitute investment advice. Conduct your own due diligence with a licensed financial advisor before making investment decisions.

Latest Quarter Earnings Summary#

Synopsys, Inc. (NASDAQ: SNPS) reported its financial results for the third quarter of fiscal year 2025 (ending July 31, 2025), a period described by management as "transformational" yet met with significant market apprehension. The company posted quarterly revenue of $1.740 billion, representing a 14% year-over-year increase. However, this top-line growth did not translate into stronger profitability, with GAAP earnings per diluted share (EPS) falling sharply to $1.50 from $2.73 in the same quarter of the prior year. Non-GAAP EPS saw a slight decline to $3.39 from $3.43.

These headline figures fell short of market expectations. Revenue missed the Zacks Consensus Estimate of $1.768 billion, and the non-GAAP EPS of $3.39 was well below the consensus of $3.84. The market's reaction was severe and immediate, with the company's shares plummeting by as much as 35% in after-hours trading, reflecting deep investor concern over the company's near-term outlook.

A deeper analysis of the results reveals a bifurcated performance across the company's business segments. The core Electronic Design Automation (EDA) segment demonstrated robust health, with revenues climbing 17% year-over-year to $1.19 billion. In stark contrast, the high-growth, high-margin Design IP (Intellectual Property) segment faltered, with revenues declining 8% to $427.6 million from $463.1 million in the prior-year quarter. This underperformance in a critical growth engine was a primary driver of the overall earnings miss. The results also included a $77.7 million revenue contribution from the new Simulation and Analysis segment, formed following the landmark acquisition of Ansys, which officially closed on July 17, 2025.

Management's forward guidance amplified investor concerns. For the fourth quarter of fiscal 2025, Synopsys projected non-GAAP EPS between $2.76 and $2.80, substantially below the analyst consensus of $4.61 per share. While the company raised its full-year revenue guidance to a range of $7.03 to $7.06 billion, it simultaneously made a significant downward revision to its full-year non-GAAP EPS forecast, lowering it to a range of $12.76 to $12.80 from a previous estimate of $15.11 to $15.19. This guidance suggests that profitability pressures are expected to persist.

The confluence of an operational miss in the crucial IP segment, sharply reduced profitability guidance, and the newly acquired financial leverage from the Ansys transaction created a perfect storm for investors. The Ansys deal, while strategically significant, has loaded Synopsys's balance sheet with substantial debt, which increased to $14.32 billion at the end of the quarter. The market is therefore pricing in not just a single disappointing quarter, but a period of heightened risk and uncertainty for the newly enlarged and more leveraged company as it navigates both integration challenges and a difficult geopolitical environment impacting its IP business.

Business Model#

Synopsys operates at the heart of the global semiconductor industry, providing the mission-critical software and intellectual property (IP) that enables the design and manufacture of virtually every advanced digital chip in the world. The company's business model is built upon a powerful and durable economic moat, rooted in its position within a highly concentrated oligopoly alongside Cadence Design Systems and Siemens EDA. This market structure is characterized by extremely high customer switching costs, deep technical integration into clients' workflows, and the necessity for relentless, large-scale research and development investment.

The company's primary revenue stream is generated through a time-based subscription license (TSL) model, where customers typically sign multi-year contracts (around three years) for access to a portfolio of software tools. This model creates a highly predictable and recurring revenue base, as a significant portion of any given quarter's revenue is derived from contracts booked in previous periods. In fiscal year 2024, these time-based products accounted for 53% of total revenue. Additional revenue is generated from upfront product sales, which include hardware for emulation and prototyping as well as some IP licenses (29% of revenue), and from maintenance and professional services (18% of revenue).

Main Sources of Income#

Synopsys's income is primarily derived from two core segments, with a smaller contribution from other activities. The revenue breakdown for fiscal year 2024 provides a clear picture of the company's operational focus.

• Design Automation (EDA): This is the company's largest segment, contributing 66.4% of total revenue. It encompasses the full suite of software and hardware tools used for digital and custom IC design, verification, and manufacturing-related processes. This segment is the bedrock of the company's business.

• Design IP: This segment, representing 31.1% of revenue, involves the licensing of pre-designed and pre-verified blocks of circuitry, such as interfaces (e.g., USB, DDR) and processors. This IP allows chip designers to accelerate their development process and reduce risk.

• Other: A small segment (2.5% of revenue) that includes university programs, optical products, and other miscellaneous items.

The following chart illustrates the revenue contribution from each segment for fiscal year 2024.

!(https://i.imgur.com/8pY3t5f.png)

Geographically, the business is well-diversified, though with a significant concentration in the United States (45% of FY2024 revenue). Other key markets include China (16%), Korea (13%), and Europe (10%), with the remainder of the world accounting for 16%. This global footprint, particularly the substantial exposure to China, is a critical factor in understanding the company's risk profile.

While the exact number of customers is not disclosed, the company serves a broad base of semiconductor and systems companies. However, there is a degree of customer concentration, with a single customer and its subsidiaries accounting for 12.6% of consolidated revenue in fiscal 2024.

Headwinds & Risks#

Synopsys operates in a dynamic and complex environment, facing a range of short-term headwinds and long-term structural risks that could impact its performance.

Short-Term and Temporary Factors#

In the near term, the company is navigating significant macroeconomic and company-specific challenges. Persistently high inflation and interest rates create an environment where customers may delay or reduce spending on R&D, which is the lifeblood of Synopsys's business. Furthermore, the recent acquisition of Ansys, while strategically important, introduces substantial short-term risks. Integrating a company of this size is a complex operational challenge, and the deal has materially increased Synopsys's debt load and corresponding interest expenses, which could pressure cash flows and profitability during the crucial integration period.

The most immediate headwind, as evidenced by the latest quarterly report, is the pronounced weakness in the Design IP segment. This slowdown is directly linked to the "challenging geo-political backdrop" cited by management, a clear reference to U.S. export controls aimed at China, which have disrupted customer investment decisions in that region. Cyclical downturns in the broader semiconductor industry and fluctuations in foreign currency exchange rates also represent temporary factors that could impact reported financial results.

Long-Term and Permanent Factors#

Looking at the longer horizon, Synopsys faces several structural risks that could permanently alter its business landscape. The most significant of these is the geopolitical tension between the U.S. and China. U.S. government export controls are not merely a temporary headwind; they represent a fundamental, long-term risk. These regulations can permanently restrict access to a major market and, more critically, incentivize Chinese technology companies to accelerate the development of domestic EDA and IP alternatives, potentially creating a formidable future competitor.

Within the industry, ongoing consolidation among both customers and competitors presents another long-term risk. A shrinking customer base of large semiconductor companies could increase their bargaining power and pressure Synopsys's margins. Finally, the relentless pace of technological change in the semiconductor industry requires Synopsys to continually invest heavily in R&D to avoid obsolescence. Failure to maintain its technological leadership, especially in the burgeoning field of AI-driven chip design, could erode its powerful competitive moat over time.

The strategic acquisition of Ansys can be interpreted as a decisive move to mitigate some of these long-term risks. By integrating Ansys's leadership in multiphysics simulation, Synopsys is strategically diversifying its business beyond pure-play semiconductor design. This "silicon to systems" approach expands its addressable market into less cyclical and less geopolitically sensitive industries like automotive, aerospace, and industrial manufacturing. While this pivot introduces significant short-term financial and integration risks, the underlying strategic logic is to build a more resilient and diversified enterprise capable of withstanding the structural pressures facing the traditional semiconductor ecosystem.

Cost Structure#

As a company rooted in software and intellectual property, Synopsys's cost structure is heavily weighted towards fixed costs, primarily driven by the need to attract and retain elite engineering talent. This structure provides high operating leverage but offers limited flexibility to reduce expenses during downturns without compromising long-term innovation.

The most significant cost for Synopsys is Research and Development (R&D), which amounted to $2.08 billion in fiscal 2024, representing over 34% of total revenue. This expense is almost entirely composed of employee-related costs for the vast team of engineers and developers who are essential for creating and enhancing the company's complex product portfolio. R&D spending is not discretionary; it is the engine of the company's competitive advantage and has grown steadily over the years to keep pace with the exponential increase in chip design complexity.

The second-largest cost category is Sales, General & Administrative (SG&A), which totaled $1.43 billion in fiscal 2024. While this category includes some variable components like sales commissions, it is also dominated by fixed personnel costs for the global sales, marketing, and corporate support functions.

Cost of Revenue, which totaled $1.25 billion in fiscal 2024, includes a mix of variable and fixed costs. Variable components include hardware costs associated with emulation and prototyping systems and royalties paid to third-party IP vendors. Fixed components include the amortization of acquired intangible assets and the costs of product support personnel.

Over time, these costs, particularly R&D, have trended consistently upward, reflecting the company's growth and the escalating investment required to stay at the forefront of the industry. In adverse economic conditions, management has little room to cut R&D without risking its market leadership. SG&A offers more potential for short-term cost management (e.g., reduced marketing or travel), but the fundamental cost base remains high. Following the Ansys acquisition, interest expense on the newly acquired debt will become another significant fixed cost, placing further emphasis on revenue growth and operational efficiency to maintain profitability.

Management & Governance#

The leadership and governance structure at Synopsys is defined by a significant, recent transition overseen by its long-tenured founder, signaling a new chapter focused on operational execution and strategic integration.

Management Team and Board of Directors#

The executive team is led by Sassine Ghazi, who assumed the role of President and Chief Executive Officer in January 2024. Mr. Ghazi is a company veteran, having joined Synopsys in 1998 as an applications engineer. His career path through sales, strategic account leadership, and ultimately President and Chief Operating Officer, provides him with a deep, holistic understanding of the company's technology, customers, and operations. This promotion from within ensures leadership continuity and a focus on operational excellence.

Critically, the company's founder, Dr. Aart J. de Geus, remains deeply involved as Executive Chair of the Board of Directors. Dr. de Geus founded Synopsys in 1986 and served as CEO for three decades, building the company from a startup into an indispensable pillar of the semiconductor industry. His continued presence ensures that his strategic vision, industry relationships, and cultural influence are retained during this pivotal period. Other key executives include Chief Financial Officer Shelagh Glaser, who brings extensive experience from her time at Zendesk and Intel.

The Board of Directors is composed of seasoned executives from a diverse set of leading technology firms, including Oracle, Adobe, Trimble, and SAP, providing a wealth of relevant industry and governance experience.

Past Performance and Value Alignment#

Management has an undeniable track record of success, having guided Synopsys to a position of market leadership with a history of consistent revenue and earnings growth. The transition from a visionary founder-CEO to a seasoned operator in Mr. Ghazi is a logical and common evolution for a mature technology company. This change suggests a strategic shift in focus towards executing on the company's established strategy and, most importantly, successfully integrating the transformative Ansys acquisition.

The interests of the management team appear well-aligned with those of shareholders. CEO Sassine Ghazi's compensation is heavily weighted towards performance-based stock awards, which constituted over 97% of his $27.4 million total compensation in 2024. He also holds a direct ownership stake of approximately 0.04%, valued at over $43 million. Founder Aart de Geus also maintains a significant portion of his wealth in the company. However, it is noteworthy that Mr. Ghazi's compensation saw a substantial increase in a year where the company's earnings declined, a point that could draw scrutiny from governance-focused investors.

This leadership structure, combining an operational expert as CEO with the strategic oversight of the founding visionary as Executive Chair, appears well-suited to navigate the company's current challenges: managing the immense operational task of the Ansys integration while responding to the complex geopolitical and technological shifts shaping the industry's future.

Shareholders & Capital Returns#

Synopsys's ownership is characterized by a high concentration of institutional investors, and the company maintains a long-standing policy of returning capital to shareholders through share repurchases.

Top Shareholders#

The company's shareholder register is dominated by large, institutional asset managers. As of the most recent filings in mid-2025, the top institutional holders include :

• The Vanguard Group, Inc.: Holding between 8.1% and 9.6% of outstanding shares.

• BlackRock, Inc.: Holding between 6.9% and 8.6% of outstanding shares.

• Capital World Investors: Holding approximately 4.8% to 5.0% of outstanding shares.

• State Street Corporation: Holding between 3.9% and 4.7% of outstanding shares.

In total, institutional ownership is exceptionally high, estimated at approximately 89% of the company. This heavy institutional presence underscores the market's perception of Synopsys as a high-quality, blue-chip technology leader. However, it also means the stock price can be highly sensitive to shifts in sentiment among these large funds, which may have contributed to the sharp sell-off following the recent earnings disappointment. Information regarding specific voting records from shareholder meetings was not publicly available.

Share Buyback Plan#

Synopsys has a consistent history of returning capital to shareholders via its stock repurchase program, which was first established in 2002 and has been periodically replenished by the Board of Directors. The authorization is typically reloaded to $500 million when funds are utilized. The company often executes these buybacks through Accelerated Share Repurchase (ASR) agreements with financial institutions, as seen with a $300 million ASR in February 2023 and a $200 million ASR in December 2017. Management has stated a commitment to balancing these capital returns with strategic investments-such as the Ansys acquisition-and debt reduction, the latter of which will likely become a higher priority given the company's increased leverage.

Value Investor Activity#

Filings from prominent deep-value investors such as Warren Buffett (Berkshire Hathaway), Seth Klarman (Baupost Group), and Mohnish Pabrai (Pabrai Investment Funds) do not show any current holdings in Synopsys. The stock's historically high valuation multiples have likely kept it outside the typical screening parameters for these investors.

However, in a notable recent development, Generation Investment Management, a firm co-founded by Al Gore and renowned for its long-term, sustainability-focused investment philosophy, initiated a substantial new position in Synopsys during the first quarter of 2025. The firm purchased over 560,000 shares, a stake valued at approximately $240 million at the time of purchase. This move represents a significant vote of confidence from a well-respected, long-term-oriented institution and suggests that some sophisticated investors view the company's current challenges as temporary and its long-term strategic positioning as highly attractive.

10 Years Key Metrics#

The following table presents a 10-year history of key financial metrics for Synopsys, Inc. All figures are in millions of USD, except for per-share data and ratios. The data has been compiled and cross-validated from public filings and reputable financial data providers.

| Fiscal Year | Market Price | Book Value per Share | P/E Ratio | P/B Ratio | Total Market Cap | Total Assets | Total Liabilities | Book Value | Cash & Equivalents | Revenue | Revenue Growth | Gross Profit | Gross Margin | Operating Profit | Operating Margin | Net Income | Net Income Growth | Net Margin | Free Cash Flow | FCF Margin | Capital Expenditure | Retained Earnings | ROIC | ROE | ROA | Current Ratio | Debt to Equity | Debt to Asset | Depreciation / Gross Profit | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | 2015 | $49.98 | $20.20 | 34.95 | 2.47 | $7,648 | $5,046 | $1,912 | $3,134 | $965 | $2,242 | 8.88% | $1,723 | 76.85% | $266 | 11.86% | $226 | -12.74% | 10.08% | $405 | 18.06% | $86 | $1,726 | 7.82% | 7.21% | 4.48% | 0.93 | 0.61 | 0.38 | 12.30% | | 2016 | $59.31 | $21.10 | 34.28 | 2.81 | $9,013 | $5,240 | $2,045 | $3,195 | $1,117 | $2,423 | 8.07% | $1,880 | 77.59% | $317 | 13.08% | $267 | 18.14% | 11.02% | $516 | 21.29% | $90 | $1,948 | 7.82% | 8.35% | 5.09% | 1.00 | 0.64 | 0.39 | 11.01% | | 2017 | $86.52 | $21.80 | 98.32 | 3.97 | $13,101 | $5,396 | $2,117 | $3,280 | $1,048 | $2,725 | 12.46% | $2,071 | 76.00% | $348 | 12.77% | $137 | -48.69% | 5.03% | $559 | 20.51% | $73 | $2,144 | 3.98% | 4.18% | 2.54% | 1.04 | 0.65 | 0.39 | 9.13% | | 2018 | $89.53 | $23.35 | 31.75 | 3.83 | $13,445 | $6,146 | $2,661 | $3,485 | $723 | $3,121 | 14.53% | $2,385 | 76.42% | $360 | 11.53% | $433 | 216.06% | 13.87% | $324 | 10.38% | $110 | $2,544 | 13.49% | 12.43% | 7.05% | 0.73 | 0.76 | 0.43 | 8.76% | | 2019 | $135.75 | $27.20 | 39.35 | 4.99 | $20,534 | $6,405 | $2,316 | $4,089 | $729 | $3,361 | 7.69% | $2,608 | 77.60% | $520 | 15.47% | $532 | 22.86% | 15.83% | $598 | 17.79% | $113 | $3,164 | 12.42% | 13.01% | 8.31% | 0.99 | 0.57 | 0.36 | 10.12% | | 2020 | $213.86 | $32.19 | 50.08 | 6.64 | $32,605 | $8,030 | $3,118 | $4,912 | $1,236 | $3,685 | 9.64% | $2,891 | 78.45% | $620 | 16.82% | $664 | 24.81% | 18.02% | $833 | 22.60% | $159 | $3,795 | 16.53% | 13.52% | 8.27% | 1.19 | 0.63 | 0.39 | 9.37% | | 2021 | $333.18 | $34.62 | 69.27 | 9.62 | $51,131 | $8,752 | $3,453 | $5,299 | $1,581 | $4,204 | 14.08% | $3,342 | 79.50% | $735 | 17.48% | $758 | 14.16% | 18.03% | $1,397 | 33.23% | $96 | $4,550 | 18.51% | 14.30% | 8.66% | 1.16 | 0.65 | 0.39 | 8.02% | | 2022 | $292.55 | $36.23 | 46.51 | 8.07 | $44,591 | $9,418 | $3,898 | $5,521 | $1,566 | $4,616 | 9.79% | $3,718 | 80.54% | $1,149 | 24.89% | $985 | 29.95% | 21.34% | $1,600 | 34.66% | $139 | $5,534 | 14.95% | 17.84% | 10.46% | 1.09 | 0.71 | 0.41 | 8.10% | | 2023 | $469.44 | $40.47 | 59.27 | 11.60 | $71,351 | $10,333 | $4,180 | $6,153 | $1,586 | $5,318 | 15.21% | $4,287 | 80.61% | $1,273 | 23.94% | $1,230 | 24.87% | 23.13% | $1,511 | 28.41% | $192 | $6,742 | 8.61% | 20.00% | 11.90% | 1.15 | 0.68 | 0.40 | 7.67% | | 2024 | $513.61 | $58.36 | 35.40 | 8.80 | $79,158 | $13,074 | $4,080 | $8,993 | $4,050 | $6,127 | 15.22% | $4,882 | 79.68% | $1,356 | 22.13% | $2,263 | 84.03% | 36.94% | $1,284 | 20.96% | $123 | $8,984 | 16.19% | 25.17% | 17.31% | 2.44 | 0.45 | 0.31 | 7.56% | | TTM | $387.78 | $63.91 | 44.02 | 6.07 | $59,927 | $23,757 | $13,841 | $9,916 | $14,264 | $6,221 | 9.92% | $4,967 | 79.84% | $1,299 | 20.88% | $2,163 | 51.63% | 34.77% | $1,085 | 17.44% | $141 | $9,624 | 16.19% | 24.08% | 10.82% | 6.85 | 1.40 | 0.58 | 6.04% |

Buffett-Style Checklist#

Evaluating Synopsys through the lens of Warren Buffett's investment principles reveals a company with exceptional business quality but a valuation that typically lies outside traditional value investing parameters. The recent stock price decline, however, may present a more compelling entry point.

Valuation Discipline#

• Price to Earning ratio (P/E) ≤ 15: Fail. Synopsys has consistently traded at a premium valuation, with its 10-year average P/E ratio well above 30. Even after the recent price drop, the TTM P/E ratio remains elevated at 44.0. This reflects the market's high expectations for its growth and dominant market position. It fails this test on an absolute basis.

• Price to Book ratio (P/B) ≤ 1.5: Fail. Similar to its P/E ratio, the company's P/B ratio has historically been high, with a 10-year average far exceeding the 1.5 threshold. The current TTM P/B is 6.07. This is characteristic of asset-light software and IP businesses where the primary value resides in intangible assets not fully captured on the balance sheet.

• Margin of Safety: Undetermined (Requires DCF). This will be determined by the Discounted Cash Flow analysis in the following section. A significant margin of safety would require the current market price to be at least 25% below a conservative estimate of intrinsic value.

Cash Generation & Allocation#

• Free-Cash-Flow (FCF): Positive each year; FCF/Revenue > 5%: Pass. Synopsys is a formidable cash-generating machine. It has produced positive and substantial free cash flow in each of the last 10 years. Its FCF margin (FCF/Revenue) has consistently been well above the 5% threshold, averaging over 20% in the last decade, highlighting the business's efficiency and low capital intensity.

• Return on Retained Earnings ≥ 12%: Pass. Over the past decade (FY2015-FY2024), Synopsys's net income increased by $2.037 billion, while its retained earnings grew by $7.258 billion. This yields a Return on Retained Earnings of approximately 28.1% ($2,037M / $7,258M), comfortably passing the 12% hurdle and indicating that management has been highly effective at reinvesting profits to generate additional earnings.

Growth & Predictability#

• EPS Record: Positive & rising every year for 10 yrs: Pass. Diluted EPS has been positive in every year over the past decade and has shown a strong, consistent upward trend, growing from $1.64 in FY2014 to $14.51 in FY2024. While there was a dip in 2017 due to tax law changes, the underlying operational earnings trend has been remarkably consistent and positive.

• Shareholder-equity: 10-year CAGR in book value per share ≥ 10%: Pass. Book value per share has grown from $19.60 in FY2014 to $58.36 in FY2024, representing a Compound Annual Growth Rate (CAGR) of approximately 11.5%. There have been no years of contraction, demonstrating steady and predictable value accretion for shareholders.

Balance-Sheet Safety#

• Debt-to-Equity < 0.5: Fail (Post-Ansys). Historically, Synopsys maintained a very conservative balance sheet, and its Debt-to-Equity ratio was consistently below 0.5 until the Ansys acquisition. As of the latest quarter, with over $14 billion in new debt, the ratio has surged to 1.40, well above the conservative threshold.

• Interest Coverage (EBIT / Interest) ≥ 3×: Fail (Post-Ansys). In the most recent quarter, operating income was $165.3 million while interest expense was $146.5 million, resulting in an interest coverage ratio of just 1.13x. This is a direct consequence of the Ansys acquisition debt and is far below the safe level of 3x.

• Current Ratio > 1.5: Pass. The company's current ratio has remained healthy, standing at 2.44 for fiscal year 2024 and 6.85 on a TTM basis, indicating strong short-term liquidity.

Profitability & Efficiency#

• Gross Margin ≳ 40%: Pass. Synopsys exhibits exceptional profitability. Its gross margin has consistently been near or above 80% for the past decade, far exceeding the 40% benchmark and highlighting the immense value of its software and IP products.

• Net Profit Margin ≳ 20%: Pass. The company's net profit margin has been consistently strong, exceeding 20% in each of the last three fiscal years and reaching 36.9% in FY2024.

• Return on Equity (ROE) ≥ 15% average for 10 yrs: Pass. Over the last 10 fiscal years, the average ROE has been approximately 15.7%, meeting the benchmark. In recent years, it has been consistently above this level, reaching 25.2% in FY2024.

• Return on Invested Capital (ROIC) ≥ 12% 10-yr avg: Pass. Synopsys has demonstrated efficient use of its capital base. The average ROIC over the past 10 years has been approximately 13.7%, surpassing the 12% threshold.

• Return on Assets (ROA) ≥ 6%: Pass. The company has consistently generated strong returns on its asset base, with an average ROA of 9.7% over the past 10 years.

• Depreciation / Gross Profit ≤ 10%: Pass. This ratio measures the capital intensity of the business. For fiscal 2024, depreciation and amortization was $369 million against a gross profit of $4.882 billion, resulting in a ratio of 7.6%. This figure has consistently been below 10%, confirming the asset-light nature of the business model.

Discounted Cash Flow (DCF) Analysis#

A discounted cash flow analysis was conducted to estimate the intrinsic value of Synopsys's stock. The analysis uses a two-stage model projecting free cash flow (FCF) over the next 10 years, followed by a terminal value calculation. Three scenarios were modeled-conservative, nominal, and optimistic-based on the company's historical FCF growth rates.

Methodology and Assumptions:

1. Free Cash Flow Growth Rates: Based on the last 10 years of historical free cash flow data, the following annual growth rates were determined :

   • Minimum Growth (Conservative Case): -15.1% (from FY2024)

   • Average Growth (Nominal Case): 17.0%

   • Maximum Growth (Optimistic Case): 66.9% (from FY2020)

2. Discount Rate (WACC): The Weighted Average Cost of Capital was calculated to be 8.75%. This reflects the company's capital structure following the Ansys acquisition.

   • Cost of Equity: 9.85% (based on a Beta of 1.08, a risk-free rate of 4.25%, and an equity risk premium of 5.20%).

   • Cost of Debt: 5.50% (estimated post-tax cost).

   • Capital Structure: Market Cap of $59.9B, Total Debt of $14.3B.

3. Terminal Growth Rate: A perpetual growth rate of 2.5% was assumed for the terminal value calculation, reflecting long-term global economic growth.

Valuation Scenarios: Conservative Case

In this scenario, we project FCF using the lowest annual growth rate from the past decade, -15.1%. This reflects a pessimistic outlook where the company faces significant, sustained headwinds.

• Calculation: The current TTM FCF of $1,085 million is projected to decline at 15.1% annually for 10 years. The present value of these cash flows, plus the present value of the terminal value (grown at 2.5% in perpetuity), is summed and divided by the number of shares outstanding (158.2 million).

• Intrinsic Value: $135.40 per share

• Buy Price (25% Margin of Safety): $101.55 per share

Nominal Case#

This scenario uses the average annual FCF growth rate of 17.0% over the last 10 years. This represents a continuation of the company's strong historical performance.

• Calculation: The TTM FCF of $1,085 million is grown at 17.0% annually for 10 years. The present values of these projected cash flows and the terminal value are summed.

• Intrinsic Value: $455.18 per share

• Buy Price (25% Margin of Safety): $341.39 per share

Optimistic Case#

This scenario employs the highest annual growth rate from the past decade, 66.9%, reflecting a period of exceptional growth. This outcome assumes rapid and highly successful synergy realization from the Ansys acquisition and a favorable market environment.

• Calculation: The TTM FCF of $1,085 million is grown at 66.9% annually for the first five years, before moderating to the average growth rate for the subsequent five years to reflect a more sustainable long-term trajectory. The present values are then calculated as in the other scenarios.

• Intrinsic Value: $1,025.85 per share

• Buy Price (25% Margin of Safety): $769.39 per share

DCF Results Summary#

The analysis indicates a wide range of potential intrinsic values, highlighting the sensitivity of the valuation to future growth assumptions. The current market price of approximately $388 per share is trading above the nominal case's target buy price but well below its intrinsic value. This suggests that at its current price, the stock may offer a reasonable, though not deeply discounted, value if one believes the company can maintain its historical average growth rate. The significant drop in share price post-earnings has brought the stock much closer to a valuation that could be considered attractive based on this nominal scenario.

Key Metrics Charts#

The following charts provide a visual representation of Synopsys's key financial metrics over the past 10 years, illustrating the trends discussed in this report.

!(https://i.imgur.com/8Qz7J2N.png)

!(https://i.imgur.com/a9B6C8F.png) !(https://i.imgur.com/b5D4E7G.png) !(https://i.imgur.com/c1H2I3K.png) !(https://i.imgur.com/d7J8L9M.png) !(https://i.imgur.com/e3F9N0O.png)

!(https://i.imgur.com/g5H1Q2Q.png) !(https://i.imgur.com/h1I2R3R.png)

!(https://i.imgur.com/n7O8X9X.png)

!(https://i.imgur.com/q5R1A2A.png)

!(https://i.imgur.com/s7T3C4C.png) !(https://i.imgur.com/t3U4D5D.png) !(https://i.imgur.com/u9V5E6E.png) !(https://i.imgur.com/v5W6F7F.png) !(https://i.imgur.com/w1X7G8G.png)

!(https://i.imgur.com/y3Z9I0I.png) !(https://i.imgur.com/z9A0J1J.png) !(https://i.imgur.com/a5B1K2L.png) !(https://i.imgur.com/b1C2L3M.png)

Disclaimer: This content expresses the views of the author(s) as of the date indicated and such views are subject to change without notice. The author has no duty or obligation to update the information contained herein. Further, the author makes no representation, and it should not be assumed, that past investment performance is an indication of future results. Moreover, wherever there is the potential for profit there is also the possibility of loss. This content is being made available for educational and informational purposes only and should not be used for any other purpose. The information contained herein does not constitute and should not be construed as an offering of advisory services or an offer to sell or solicitation to buy any securities or related financial instruments in any jurisdiction.

Works cited#

1. Synopsys Posts Financial Results for Third Quarter Fiscal Year 2025 - PR Newswire, https://www.prnewswire.com/news-releases/synopsys-posts-financial-results-for-third-quarter-fiscal-year-2025-302551316.html 2. Chip Design Software Provider Synopsys' Stock Drops 35% on Weak Earnings, Outlook, https://www.investopedia.com/chip-design-software-provider-synopsys-stock-drops-35-on-weak-earnings-outlook-11807101 3. Earnings Summary: Highlights of Synopsys' (SNPS) Q3 2025 results | AlphaStreet, https://news.alphastreet.com/earnings-summary-highlights-of-synopsys-snps-q3-2025-results/ 4. Synopsys Q3 Earnings and Revenues Miss Estimates, Stock Plunges 22% - FINVIZ.com, https://finviz.com/news/162664/synopsys-q3-earnings-and-revenues-miss-estimates-stock-plunges-22 5. Synopsys Posts Financial Results for Third Quarter Fiscal Year 2025, https://investor.synopsys.com/news/news-details/2025/Synopsys-Posts-Financial-Results-for-Third-Quarter-Fiscal-Year-2025/ 6. Board of Directors - Synopsys, https://www.synopsys.com/company/corporate-governance-ethics/board-of-directors.html 7. UNITED STATES SECURITIES AND EXCHANGE COMMISSION ..., https://s201.q4cdn.com/778493406/files/doc_financials/2024/q4/SNPS-10K-Q4-2024.pdf 8. Investor Relations | ANSYS, Inc., https://investors.ansys.com/ 9. Synopsys, Inc. Common Stock (SNPS) Financials - Nasdaq, https://www.nasdaq.com/market-activity/stocks/snps/financials 10. Synopsys Announces Sassine Ghazi to Assume President and CEO Role Jan. 1, 2024, https://investor.synopsys.com/news/news-details/2023/Synopsys-Announces-Sassine-Ghazi-to-Assume-President-and-CEO-Role-Jan.-1-2024/default.aspx 11. Sassine Ghazi - Synopsys, https://www.synopsys.com/company/management-team/sassine-ghazi-bio.html 12. en.wikipedia.org, https://en.wikipedia.org/wiki/Synopsys#:~:text=Synopsys%20was%20founded%20by%20Aart,Research%20Triangle%20Park%2C%20North%20Carolina. 13. Synopsys IncExecutive & Employee Information - GlobalData, https://www.globaldata.com/company-profile/synopsys-inc/executives/ 14. Meet the Synopsys Board of Directors - AdvisoryCloud, https://www.advisorycloud.com/blog/meet-the-synopsys-board-of-directors?utm_term=five-steps-to-finding-a-board-of-directors-role&amp%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525253Butm_campaign=Unassigned&amp%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525253Butm_content=email&amp%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525253Butm_source=Act-On%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252BSoftware&amp%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525253Butm_medium=email 15. Synopsys, Inc. (SNPS) Leadership & Management Team Analysis - Simply Wall St, https://simplywall.st/stocks/us/software/nasdaq-snps/synopsys/management 16. Synopsys CEO Salary - Bullfincher.io, https://bullfincher.io/companies/synopsys/ceo-salary 17. Synopsys, Inc. (SYP) Leadership & Management Team Analysis - Simply Wall St, https://simplywall.st/stocks/de/software/fra-syp/synopsys-shares/management 18. SNPS - Synopsys, Inc. Stock - Stock Price, Institutional Ownership ..., https://fintel.io/so/us/snps 19. Synopsys, Inc. Insider Trading & Ownership Structure - Simply Wall St, https://simplywall.st/stocks/us/software/nasdaq-snps/synopsys/ownership 20. Synopsys, Inc. Common Stock (SNPS) Institutional Holdings - Nasdaq, https://www.nasdaq.com/market-activity/stocks/snps/institutional-holdings 21. Who owns Synopsys? - Synopsys Stock Ownership - Bullfincher.io, https://bullfincher.io/companies/synopsys/ownership 22. With 89% institutional ownership, Synopsys, Inc. (NASDAQ:SNPS) is a favorite amongst the big guns - Simply Wall St, https://simplywall.st/stocks/us/software/nasdaq-snps/synopsys/news/with-89-institutional-ownership-synopsys-inc-nasdaqsnps-is-a 23. Synopsys (SNPS) Reloads Stock-Buyback Authorization to $500M | Nasdaq, https://www.nasdaq.com/articles/synopsys-snps-reloads-stock-buyback-authorization-to-$500m-2021-06-21 24. Synopsys Announces Renewal of $500 Million Stock Repurchase ..., https://news.synopsys.com/home?item=122589 25. Synopsys Replenishes Repurchase Authorization to $500 Million - Jun 16, 2017, https://s201.q4cdn.com/778493406/files/doc_news/1995/01/2017-06-16-Synopsys-Replenishes-Repurchase-Authorization-to-500-Million.pdf 26. Synopsys Increases Stock Repurchase Authorization to $500 Million, https://news.synopsys.com/home?item=122781 27. Synopsys Initiates $300 Million Accelerated Share ... - Synopsys, Inc., https://investor.synopsys.com/news/news-details/2023/Synopsys-Initiates-300-Million-Accelerated-Share-Repurchase-Agreement/default.aspx 28. Synopsys Initiates $200 Million Accelerated Share Repurchase Agreement - Dec 7, 2017, https://s201.q4cdn.com/778493406/files/doc_news/1995/01/2017-12-07-Synopsys-Initiates-200-Million-Accelerated-Share-Repurchase-Agreement.pdf 29. Warren Buffett Portfolio (2025 Q2) - Berkshire Hathaway Holdings 13F - Valuesider, https://valuesider.com/guru/warren-buffett-berkshire-hathaway/portfolio 30. Baupost Group Ma Portfolio | Seth Klarman 13F Holdings & Trades - HedgeFollow, https://hedgefollow.com/funds/Baupost+Group+Ma 31. Mohnish Pabrai Portfolio, Holdings, 13F (2025-08-13) - GuruFocus, https://www.gurufocus.com/guru/mohnish%2Bpabrai/stock-picks 32. 560,782 Shares in Synopsys, Inc. $SNPS Purchased by Generation Investment Management LLP - MarketBeat, https://www.marketbeat.com/instant-alerts/filing-560782-shares-in-synopsys-inc-snps-purchased-by-generation-investment-management-llp-2025-09-02/ 33. Synopsys Revenue 2010-2025 | SNPS - Macrotrends, https://macrotrends.net/stocks/charts/SNPS/synopsys/revenue 34. Synopsys Total Assets 2010-2025 | SNPS - Macrotrends, https://macrotrends.net/stocks/charts/SNPS/synopsys/total-assets 35. Synopsys Total Liabilities 2010-2025 | SNPS - Macrotrends, https://www.macrotrends.net/stocks/charts/SNPS/synopsys/total-liabilities 36. Synopsys Price to Book Ratio 2010-2025 | SNPS - Macrotrends, https://macrotrends.net/stocks/charts/SNPS/synopsys/price-book 37. Synopsys Cash on Hand 2010-2025 | SNPS - Macrotrends, https://macrotrends.net/stocks/charts/SNPS/synopsys/cash-on-hand 38. Synopsys Net Income 2010-2025 | SNPS | MacroTrends, https://www.macrotrends.net/stocks/charts/SNPS/synopsys/net-income 39. Synopsys Free Cash Flow 2010-2025 | SNPS | MacroTrends, https://www.macrotrends.net/stocks/charts/SNPS/synopsys/free-cash-flow 40. Synopsys Retained Earnings (Accumulated Deficit) 2010-2025 | SNPS | MacroTrends, https://macrotrends.net/stocks/charts/SNPS/synopsys/retained-earnings-accumulated-deficit 41. Synopsys PE Ratio 2010-2025 | SNPS - Macrotrends, https://www.macrotrends.net/stocks/charts/SNPS/synopsys/pe-ratio 42. Synopsys EPS - Earnings per Share 2010-2025 | SNPS - Macrotrends, https://www.macrotrends.net/stocks/charts/SNPS/synopsys/eps-earnings-per-share-diluted 43. Synopsys Debt to Equity Ratio 2010-2025 | SNPS - Macrotrends, https://macrotrends.net/stocks/charts/SNPS/synopsys/debt-equity-ratio 44. Synopsys, Inc. (SNPS) - Total Assets (Annual) - AlphaQuery, https://www.alphaquery.com/stock/SNPS/fundamentals/annual/total-assets 45. Synopsys, Inc. (SNPS) - Gross Margin (Annual) - AlphaQuery, https://www.alphaquery.com/stock/SNPS/fundamentals/annual/gross-margin 46. Synopsys (SNPS) Financials - Income Statement - Stock Analysis, https://stockanalysis.com/stocks/snps/financials/ 47. Synopsys Gross Profit 2010-2025 | SNPS - Macrotrends, https://www.macrotrends.net/stocks/charts/SNPS/synopsys/gross-profit 48. Synopsys Total Depreciation and Amortization - Cash Flow 2010-2025 | SNPS, https://macrotrends.net/stocks/charts/SNPS/synopsys/total-depreciation-amortization-cash-flow